Bio-Rad Investor Accuses Board Of Rampant Malfeasance
A Bio-Rad Laboratories Inc. institutional investor accused the lab-equipment giant's board on Tuesday of letting the company "careen out of control" before a $55 million foreign-bribery settlement with federal agencies, and...To view the full article, register now.
Already a subscriber? Click here to view full article